Trade Vertex Pharmaceuticals Incorporated - VRTX CFD
Add to favourite- Summary
- Historical Data
| Spread | 1.62 | ||||||||
|
Long position overnight fee
Long position overnight funding adjustment
Go to platform | -0.023457% | ||||||||
|
Short position overnight fee
Short position overnight funding adjustment
Go to platform | 0.001235% | ||||||||
| Overnight fee time | 21:00 (UTC) | ||||||||
| Min traded quantity | 0.1 | ||||||||
| Currency | USD | ||||||||
| Margin | 5.00% | ||||||||
| Stock exchange | United States of America | ||||||||
| Commission on trade | 0% |
| Prev. Close | 487.95 |
| Open | 484.12 |
| 1-Year Change | 16.9% |
| Day's Range | 484.12 - 494.61 |
- Last Week
- Last Month
- Last Year
- Last two Years
- Max
- Daily
- Weekly
- Monthly
| Date | Close | Change | Change (%) | Open | High | Low |
|---|---|---|---|---|---|---|
| Mar 11, 2025 | 487.95 | -4.71 | -0.96% | 492.66 | 493.89 | 480.03 |
| Mar 10, 2025 | 499.80 | 19.60 | 4.08% | 480.20 | 503.66 | 478.03 |
| Mar 7, 2025 | 486.93 | 1.98 | 0.41% | 484.95 | 491.96 | 481.13 |
| Mar 6, 2025 | 485.58 | -1.42 | -0.29% | 487.00 | 491.11 | 478.63 |
| Mar 5, 2025 | 490.07 | 6.72 | 1.39% | 483.35 | 494.94 | 483.35 |
| Mar 4, 2025 | 487.49 | 4.83 | 1.00% | 482.66 | 489.86 | 479.83 |
| Mar 3, 2025 | 481.88 | 4.21 | 0.88% | 477.67 | 490.46 | 474.59 |
| Feb 28, 2025 | 475.77 | -1.59 | -0.33% | 477.36 | 484.05 | 471.77 |
| Feb 27, 2025 | 473.91 | -0.85 | -0.18% | 474.76 | 485.74 | 472.53 |
| Feb 26, 2025 | 478.93 | 1.98 | 0.42% | 476.95 | 484.57 | 474.05 |
| Feb 25, 2025 | 478.73 | 1.52 | 0.32% | 477.21 | 486.03 | 474.15 |
| Feb 24, 2025 | 481.61 | 0.84 | 0.17% | 480.77 | 487.34 | 476.29 |
| Feb 21, 2025 | 482.59 | 1.24 | 0.26% | 481.35 | 487.18 | 479.37 |
| Feb 20, 2025 | 480.26 | 8.26 | 1.75% | 472.00 | 481.01 | 471.80 |
| Feb 19, 2025 | 470.34 | 8.44 | 1.83% | 461.90 | 471.93 | 459.57 |
| Feb 18, 2025 | 460.64 | 4.70 | 1.03% | 455.94 | 464.58 | 449.80 |
| Feb 14, 2025 | 458.25 | -4.10 | -0.89% | 462.35 | 468.91 | 457.06 |
| Feb 13, 2025 | 461.50 | 8.98 | 1.98% | 452.52 | 464.44 | 449.99 |
| Feb 12, 2025 | 451.90 | 0.08 | 0.02% | 451.82 | 455.25 | 445.44 |
| Feb 11, 2025 | 454.88 | -2.76 | -0.60% | 457.64 | 467.12 | 451.56 |
Trading calculator
Calculate your hypothetical P&L if you had opened a CFD trade on a certain date (select a date) and closed on a different date (select a date).
- 1:1
- 2:1
- 3:1
- 5:1
- 10:1
- 20:1
- 20
- 100
- 500
- 1000
- 10000
Vertex Company profile
Vertex Pharmaceuticals Incorporated (VRTX) is a biotechnology company that develops and commercialises innovative medicines.
Founded in 1989, Vertex is headquartered in Boston, Massachusetts, with international headquarters in London, UK. The company focuses on health conditions like cystic fibrosis, pain, sickle cell disease, beta thalassemia, alpha-1 antitrypsin deficiency, APOL1-mediated kidney disease, duchenne muscular dystrophy and type 1 diabetes.
The company designed and developed Symdeko/Symkevi, Orkambi and Kalydeco for cystic fibrosis, and Trikafta for patients aged six years or older with at least one F508del mutation. There are several products in the pipeline, such as VX-864 for the treatment of AAT deficiency, VX-147 for the treatment of APOL1-mediated focal segmental glomerulosclerosis, VX- 880 for Type 1 Diabetes and VX-548, a NaV1.8 inhibitor for treatments of neuropathic and musculoskeletal pain.
Vertex sells its products to specialty pharmacies and distributors, hospitals and clinics. It has collaborations and partnership deals with CRISPR Therapeutics AG, Moderna, Arbor Biotechnologies and several other pharma companies that support the commercialisation of drugs.
The company went public in 1991. Vertex Pharmaceuticals Incorporated stock trades on the Nasdaq under the ticker symbol VRTX.
You can follow the VRTX share value and price movement live through stock charts at Capital.com.
| Industry: | Bio Therapeutic Drugs |
50 Northern Avenue
BOSTON
MASSACHUSETTS 02210
US
News
Coffee price forecast: 2025-2030 third-party coffee target
Coffee prices have cooled considerably in the past few months. Is a rebound in store or will they continue to fall?
09:42, 12 March 2025
The Simpsons predicted XRP to hit $589: Has the show got it right again?
Did the animated TV show predict a breakout for the XRP cryptocurrency?
11:00, 11 March 2025
Rolls-Royce share price forecast: third- party price target
Our Rolls-Royce share price forecast looks at the outlook for the FTSE 100-listed engineering company after a tough few years.
14:58, 10 March 2025
Gasoline petrol price forecast 2025-2030: Third-party price target
Discover third-party gasoline (petrol) price predictions for 2025 and beyond, with analyst targets, historical prices, and trading strategies.
10:27, 3 March 2025
USD forecast - third party data round up
The DXY hit a seven-month low in January, just a few months after a multi-decade peak in late September.
10:02, 27 February 2025
Microsoft Stock Price Forecast for 2025 and beyond: Third party price target
We assess the likely level of the Microsoft stock price in 5 years, and possible drivers behind the stock’s past performance. Read on...
18:29, 7 February 2025
Ripple XRP price prediction: Third-party price target
Discover the ripple (XRP) price predictions for 2025 and beyond, with analyst price targets and CFDs trading strategies on Capital.com
15:29, 6 February 2025People also watch
Still looking for a broker you can trust?
Join the 690,000+ traders worldwide that chose to trade with Capital.com